(Q37826011)

23 August 2017

Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening (English)

1 reference

23 August 2017

United States of America

1 reference

Robert A Smith

1

1 reference

23 August 2017

Vilma Cokkinides

2

1 reference

23 August 2017

Durado Brooks

3

1 reference

23 August 2017

Debbie Saslow

4

1 reference

23 August 2017

Mona Shah

5

1 reference

23 August 2017

Otis W Brawley

6

1 reference

23 August 2017

language of work or name

English

0 references

publication date

4 January 2011

1 reference

23 August 2017

1 reference

23 August 2017

61

1 reference

23 August 2017

1

1 reference

23 August 2017

8-30

1 reference

American Cancer Society guideline for the early detection of prostate cancer: update 2010

23 August 2017

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Promoting informed decisions about cancer screening in communities and healthcare systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

American Cancer Society guidelines for breast cancer screening: update 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

American Cancer Society guidelines for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

American Cancer Society guideline for the early detection of cervical neoplasia and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Global patterns of cancer incidence and mortality rates and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Public understandings of genetics and health

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

The comprehensiveness of family cancer history assessments in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Cancer screening in elderly patients: a framework for individualized decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

A breast cancer prediction model incorporating familial and personal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Multimodality screening of high-risk women: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Factors influencing choices for colorectal cancer screening among previously unscreened African and Caucasian Americans: findings from a triangulation mixed methods investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

What is most important to patients when deciding about colorectal screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Association of colonoscopy and death from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Prostate specific antigen (PSA) testing as screening for prostate cancer: The current controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Psychological reactions in men screened for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Early Lung Cancer Action Project: overall design and findings from baseline screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Prevention and early detection clinical trials: opportunities for primary care providers and their patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Survival of patients with stage I lung cancer detected on CT screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Frequency of symptoms of ovarian cancer in women presenting to primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Ovarian cancer: can we make the clinical diagnosis earlier?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Predictive value of symptoms for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

The role of CA125 in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Tumor markers for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Priorities among effective clinical preventive services: results of a systematic review and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Delivery of cancer screening: how important is the preventive health examination?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Longitudinal predictors of nonadherence to maintenance of mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Trends in colorectal cancer test use in the medicare population, 1998-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Trends in colorectal cancer screening utilization among ethnic groups in California: are we closing the gap?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Longitudinal adherence with fecal occult blood test screening in community practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Can the medical home reduce cancer morbidity and mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Primary care: is there enough time for prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Principles of the patient-centered medical home and preventive services delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

Prostate Cancer Screening Decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20096

21 January 2018

Identifiers

DOI

10.3322/CAAC.20096

1 reference

23 August 2017

1 reference